Polypharmacy and major adverse events in atrial fibrillation. Caturano A, Spiezia S, Brunelli V, Galiero R, et al. J Cardiovasc Pharmacol 2022 Aug 23. pii: 00005344-990000000-00109.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Caturano A, Spiezia S, Brunelli V, Galiero R, et al. Polypharmacy and major adverse events in atrial fibrillation. J Cardiovasc Pharmacol 2022 Aug 23. pii: 00005344-990000000-00109.
PMID: 36027584